UY31779A - FORMULATIONS FOR THE EAR TO TREAT OPTICAL DISEASES AND CONDITIONS - Google Patents

FORMULATIONS FOR THE EAR TO TREAT OPTICAL DISEASES AND CONDITIONS

Info

Publication number
UY31779A
UY31779A UY0001031779A UY31779A UY31779A UY 31779 A UY31779 A UY 31779A UY 0001031779 A UY0001031779 A UY 0001031779A UY 31779 A UY31779 A UY 31779A UY 31779 A UY31779 A UY 31779A
Authority
UY
Uruguay
Prior art keywords
ear
formulations
conditions
compositions
methods
Prior art date
Application number
UY0001031779A
Other languages
Spanish (es)
Inventor
Andrew M Trammel
Lichter Jay
Piu Fabrice
Ye Qiang
Vollrath Bendedikt
Sergio G Duron
Luis A Dellamary
Lebel Carl
Jeffrey P Harris
Michael Christopher Scaife
Original Assignee
Univ California
Otonomy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Otonomy Inc filed Critical Univ California
Publication of UY31779A publication Critical patent/UY31779A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a composiciones y métodos para el tratamiento de trastornos ópticos con agentes inmunomoduladores y moduladores de la presión del oído. En estos métodos, las composiciones y formulaciones para el oído son administradas localmente a un individuo afligido con un trastorno óptico, a través de la aplicación directa de las composiciones y formulaciones de inmunomoduladores y/o presón del oído sobre las áreas objetivo del oído medio y/o oído interno, o vía perfusión entre el estructuras del oído medio y/o oído interno.The present invention relates to compositions and methods for the treatment of optical disorders with immunomodulatory agents and ear pressure modulators. In these methods, the compositions and formulations for the ear are administered locally to an individual afflicted with an optical disorder, through the direct application of the compositions and formulations of immunomodulators and / or ear pressure on the target areas of the middle ear and / or inner ear, or via perfusion between the structures of the middle ear and / or inner ear.

UY0001031779A 2008-04-21 2009-04-21 FORMULATIONS FOR THE EAR TO TREAT OPTICAL DISEASES AND CONDITIONS UY31779A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4654308P 2008-04-21 2008-04-21

Publications (1)

Publication Number Publication Date
UY31779A true UY31779A (en) 2009-12-14

Family

ID=41665349

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001031779A UY31779A (en) 2008-04-21 2009-04-21 FORMULATIONS FOR THE EAR TO TREAT OPTICAL DISEASES AND CONDITIONS

Country Status (5)

Country Link
AR (1) AR071388A1 (en)
CL (1) CL2009000956A1 (en)
PE (1) PE20091836A1 (en)
TW (1) TWI412370B (en)
UY (1) UY31779A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI485145B (en) 2012-10-26 2015-05-21 Ind Tech Res Inst P-type organic semiconductor material and optoelectronic device utilizing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004533A2 (en) * 1993-08-04 1995-02-16 Andrulis Pharmaceuticals Corporation Treatment of rheumatoid arthritis with thalidomide alone or in combination with other anti-inflammatory agents
US6548527B2 (en) * 2000-03-27 2003-04-15 The General Hospital Corporation Treatments for immune-mediated ear disorders
US20070021352A1 (en) * 2005-07-20 2007-01-25 Cypress Bioscience, Inc. Prevention and treatment of hearing disorders

Also Published As

Publication number Publication date
TW201004633A (en) 2010-02-01
CL2009000956A1 (en) 2011-02-18
TWI412370B (en) 2013-10-21
AR071388A1 (en) 2010-06-16
PE20091836A1 (en) 2009-12-18

Similar Documents

Publication Publication Date Title
CL2018003142A1 (en) Integrated stress path modulators
BRPI0808775A2 (en) compounds and compositions as modulators of gpr119 activity
MX2020004519A (en) Modulators of the integrated stress pathway.
WO2010011609A3 (en) Controlled release antimicrobial compositions and methods for the treatment of otic disorders
CR11292A (en) COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY
CR20120625A (en) METHODS OF TREATMENT AGAINST PANCREATIC CANCER
WO2010008995A3 (en) Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders
ECSP12012171A (en) PHARMACEUTICAL COMPOSITIONS OF THE ESPIRO-OXINDOL COMPOUND FOR TOPICAL ADMINISTRATION AND ITS USES AS THERAPEUTIC AGENTS
CL2012001673A1 (en) Substituted benzamide derivative compounds, as modulators of taar; preparation procedure; pharmaceutical composition; and its use in the treatment of depression, anxiety disorders, bipolar disorder, schizophrenia, epilepsy, migraine, Alzheimer's disease, metabolic disorders, among others.
MX2014002668A (en) TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF SODIUM CHANNELS, VOLTAGE-GATED (SCNxA) WITH SMALL MOLECULES.
PE20151023A1 (en) TRIAZOLOPYRAZINES
CR20140476A (en) AGENTS TO TREAT DISORDERS INVOLVING THE MODULATION OF RIANODINE RECEPTORS
ECSP067019A (en) COMPOUNDS AND COMPOSITIONS AS RECEPTOR MODULATORS ACTIVATED BY PEROXISOM PROLIFERATOR (PPAR)
BR112018001292A2 (en) methods for better release of active agents to tumors
UY32457A (en) VACCINE OF THE INACTIVATED DENGUE VIRUS
WO2010074992A3 (en) Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
EA201690323A1 (en) METHODS OF TREATING EAR DISEASES IN CHILDREN
ECSP11011354A (en) USEFUL OPTICAL COMPOSITIONS FOR THE TREATMENT OF INTERNAL AND EXTERNAL EAR INFECTIONS IN MAÍFEROS
CL2011002766A1 (en) Carboxamide derived compounds, calpain inhibitors; pharmaceutical composition comprising them; and its use in the treatment of neurodegenerative diseases, alzahimer, pain, among others.
CL2012001031A1 (en) 2-Oxo-1-pyrrolidinyl-imidazothiadiazole derived compounds; pharmaceutical composition comprising them; useful for the treatment of epilepsy, neurological disorders, among others.
AR077372A1 (en) COMPOSITIONS AND METHODS TO TREAT OTHAL OR NASAL OPHTHALM INFECTIONS
CL2019002313A1 (en) Combination of cotinine and antioxidant for resistance to the treatment of depression and correction of the functional deficit of astrocytes induced by depression and other neuropathological conditions.
CR11529A (en) Cycloalkyloxy and heterocycloalkylpyridine compounds as modulators of HISTAMINE H3 RECEPTOR
WO2018140792A3 (en) Neurotrophin mutants for treating hearing loss and other otic disorders
EA201991488A1 (en) POTASSIUM CHANNEL MODULATORS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181025